Grass pollen allergy medication is the cornerstone of managing hay fever, one of the most common allergic conditions in the UK, affecting up to 30% of the population. Symptoms typically peak between May and July, when grass pollen counts are highest, and can range from sneezing and a blocked nose to itchy eyes and fatigue. Choosing the right treatment — whether an antihistamine, intranasal corticosteroid spray, or allergen immunotherapy — depends on symptom severity and individual circumstances. This guide covers NHS-recommended options, how each medication works, safety considerations, and when to seek specialist advice.
Summary: Grass pollen allergy is best managed with non-sedating antihistamines and intranasal corticosteroid sprays as first-line treatments, with allergen immunotherapy available for severe or poorly controlled cases.
- Non-sedating antihistamines (cetirizine, loratadine, fexofenadine) and intranasal corticosteroids (beclometasone, fluticasone, mometasone) are the NHS first-line treatments for grass pollen allergy.
- Intranasal corticosteroid sprays are the most effective single treatment for nasal symptoms and should ideally be started at least two weeks before the pollen season begins.
- Fexofenadine absorption is significantly reduced by fruit juices; it must be taken with water only, and levels may be raised by erythromycin or ketoconazole.
- Sublingual immunotherapy tablets (Grazax and Oralair) are MHRA-licensed for adults and children aged 5 and over, offering disease-modifying treatment after specialist referral.
- Decongestant nasal sprays must not be used for more than seven consecutive days due to the risk of rebound congestion (rhinitis medicamentosa).
- Red flags including a painful red eye, photophobia, reduced vision, or worsening asthma during pollen season require prompt medical assessment.
Table of Contents
Am I eligible for weight loss injections?
Find out whether you might be eligible!
Answer a few quick questions to see whether you may be suitable for prescription weight loss injections (like Wegovy® or Mounjaro®).
- No commitment — just a quick suitability check
- Takes about 1 minute to complete
Understanding Grass Pollen Allergy and Its Symptoms
Grass pollen allergy, commonly referred to as hay fever or seasonal allergic rhinitis, is one of the most prevalent allergic conditions in the United Kingdom. It is estimated that approximately 10–30% of the UK population is affected (NHS; NICE CKS: Allergic rhinitis). Symptoms typically peak between May and July in most UK regions, when grass pollen counts are at their highest, though the season can extend into August. The condition occurs when the immune system mistakenly identifies grass pollen proteins as harmful, triggering an inflammatory response mediated by immunoglobulin E (IgE) antibodies and the release of histamine.
The resulting symptoms can range from mild to significantly debilitating and commonly include:
-
Sneezing and a runny or blocked nose
-
Itchy, red, or watery eyes (allergic conjunctivitis)
-
Itching of the throat, mouth, or ears
-
Headaches and facial pressure caused by sinus congestion
-
Fatigue, which may be worsened by disrupted sleep
In individuals with asthma, grass pollen exposure can also trigger or worsen respiratory symptoms such as wheezing, chest tightness, and breathlessness. This overlap between hay fever and asthma — sometimes called the 'united airway' concept — is well recognised clinically and should prompt careful assessment. Seek an urgent or unscheduled asthma review if peak flow drops significantly or reliever inhaler use increases during the pollen season.
It is important to distinguish grass pollen allergy from other causes of rhinitis, such as perennial allergic rhinitis (triggered by dust mites or pet dander) or non-allergic rhinitis. A clear seasonal pattern, with symptoms worsening on high-pollen days and improving indoors or after rainfall, is a key diagnostic indicator.
Red flags requiring prompt medical attention include:
-
A painful red eye, photophobia, or reduced vision — seek urgent ophthalmic assessment, as these are not typical of allergic conjunctivitis
-
Fever, purulent unilateral nasal discharge, and severe facial pain — these may indicate bacterial sinusitis requiring medical review
-
Significant or worsening asthma symptoms during the pollen season
If symptoms are severe, persistent, or uncertain in origin, referral to an NHS allergy clinic for formal testing — including skin prick testing (SPT) or specific IgE blood tests — may be appropriate, in line with NICE CKS and BSACI guidance. Testing is also indicated when immunotherapy is being considered.
NHS-Recommended Medications for Grass Pollen Allergy
NICE CKS (Allergic rhinitis) and BSACI guidance provide clear recommendations on the stepwise management of allergic rhinitis, including grass pollen allergy. First-line treatment typically involves non-sedating antihistamines, intranasal corticosteroid sprays, and, where eye symptoms are prominent, topical antihistamine or mast cell stabiliser eye drops. The choice of medication depends on the predominant symptoms, their severity, and individual patient factors such as age and comorbidities.
For mild, intermittent symptoms, a non-sedating oral antihistamine such as cetirizine, loratadine, or fexofenadine is usually recommended. These are available over the counter at pharmacies and are generally well tolerated. Fexofenadine 120 mg is licensed for adults and children aged 12 years and over. If symptoms are predominantly nasal, an intranasal corticosteroid spray — such as beclometasone dipropionate, fluticasone propionate, or mometasone furoate — should be considered as first-line or add-on therapy, as these have the strongest evidence base for controlling nasal inflammation (NICE CKS: Allergic rhinitis). Beclometasone dipropionate and fluticasone propionate nasal sprays are available over the counter for adults aged 18 years and over; mometasone furoate nasal spray is available from pharmacies without a prescription for adults aged 18 years and over.
For moderate-to-severe or persistent symptoms, combining an intranasal corticosteroid with an oral antihistamine is recommended. A fixed-dose intranasal azelastine/fluticasone propionate combination spray (prescription-only) is an option for moderate-to-severe symptoms that are inadequately controlled on monotherapy, in line with BSACI guidance. If nasal congestion remains problematic, a short course of a topical decongestant (such as xylometazoline nasal spray) may be used, but this should not exceed seven consecutive days due to the risk of rebound congestion (rhinitis medicamentosa). Oral decongestants should be avoided in patients with uncontrolled hypertension, cardiovascular disease, or those taking monoamine oxidase inhibitors (MAOIs). Oral corticosteroids are occasionally prescribed for very severe, short-term symptom control but are not recommended for routine use due to their systemic side-effect profile.
Patients are encouraged to begin preventative treatment at least two weeks before the expected pollen season to allow intranasal corticosteroids to reach their full anti-inflammatory effect. Pharmacists play a key role in advising on appropriate over-the-counter options, and GP referral should be considered when symptoms are inadequately controlled despite optimal first-line therapy.
Antihistamines, Nasal Sprays, and Eye Drops Explained
Understanding how each class of grass pollen allergy medication works helps patients use them more effectively and with greater confidence.
Oral antihistamines work by competitively blocking H1 histamine receptors, thereby reducing sneezing, itching, and rhinorrhoea triggered by histamine release. Second-generation antihistamines — such as cetirizine (10 mg once daily), loratadine (10 mg once daily), and fexofenadine (120 mg once daily) — are preferred over first-generation agents such as chlorphenamine because they cause significantly less sedation and have a longer duration of action. However, even second-generation antihistamines can cause drowsiness in some individuals, and patients should be advised to exercise caution when driving or operating machinery.
Important interactions to be aware of:
-
Fexofenadine absorption is significantly reduced by fruit juices (including grapefruit, orange, and apple juice); take with water only. Fexofenadine levels may be increased by erythromycin or ketoconazole — seek pharmacist or GP advice if taking these medicines.
-
Sedating antihistamines (e.g., chlorphenamine) interact with alcohol, other CNS depressants, and certain antidepressants; avoid driving and operating machinery.
Intranasal corticosteroid sprays are considered the most effective single treatment for allergic rhinitis. They work by reducing local mucosal inflammation, suppressing the release of inflammatory mediators, and decreasing nasal hyperresponsiveness. Common options include:
-
Beclometasone dipropionate (e.g., Beconase) — available over the counter for adults aged 18 years and over
-
Fluticasone propionate (e.g., Flixonase) — available over the counter for adults aged 18 years and over
-
Mometasone furoate (e.g., Nasonex) — available from pharmacies without a prescription for adults aged 18 years and over
These sprays must be used regularly and correctly — directed towards the outer wall of the nostril, away from the nasal septum — to be effective and to minimise the small risk of nasal bleeding or septal perforation with long-term use (NHS: How to use nasal sprays).
Antihistamine eye drops such as azelastine or olopatadine provide rapid relief from ocular symptoms. Sodium cromoglicate eye drops, a mast cell stabiliser, are a well-established alternative, particularly for children, though they require more frequent dosing. Ketotifen eye drops may also be available over the counter in some UK pharmacies. For contact lens wearers and those using drops frequently, preservative-free formulations are preferable.
Ocular red flags: A painful red eye, photophobia, or any reduction in vision are not typical of allergic conjunctivitis and require urgent ophthalmic assessment. If eye symptoms are severe or unresponsive to treatment, referral to an ophthalmologist or allergy specialist should be considered.
Immunotherapy Options Available in the UK
For patients whose grass pollen allergy symptoms remain poorly controlled despite optimal pharmacotherapy, allergen immunotherapy (AIT) offers a disease-modifying treatment option. Unlike conventional medications, which suppress symptoms, immunotherapy works by gradually desensitising the immune system to grass pollen allergens, potentially providing long-term relief even after treatment is completed.
In the UK, two main forms of immunotherapy are available for grass pollen allergy:
-
Subcutaneous immunotherapy (SCIT): Involves a series of injections of gradually increasing doses of allergen extract, administered in a clinical setting under medical supervision. This approach requires regular hospital or clinic attendance and carries a small risk of systemic allergic reactions, including anaphylaxis, which is why patients must be observed for at least 30 minutes after each injection.
-
Sublingual immunotherapy (SLIT): Involves placing allergen tablets under the tongue. Two MHRA-licensed grass pollen SLIT tablets are available in the UK: Grazax (ALK) and Oralair (5-grass pollen tablet, Stallergenes Greer). Both are taken daily and are typically started at least four months before the pollen season. SLIT is generally considered to have a more favourable safety profile than SCIT and, after the first dose is taken under medical supervision, can be administered at home.
Both Grazax and Oralair are licensed for adults and children aged 5 years and over, as per their UK Summaries of Product Characteristics (SmPCs). Treatment is typically recommended for a minimum of three years to achieve sustained benefit, in line with NICE CKS (Allergic rhinitis) and BSACI guidance.
Immunotherapy is not suitable for everyone. Key contraindications and cautions include:
-
Severe or uncontrolled asthma
-
Significant cardiovascular conditions
-
Use of beta-blockers (particularly a contraindication for SCIT)
-
Immunotherapy should not be initiated during pregnancy
-
SLIT should be paused if there is active inflammation or ulceration in the mouth
Referral to a specialist NHS allergy or clinical immunology service is required to assess suitability and to initiate treatment. All immunotherapy is specialist-initiated.
How to Use Allergy Medications Safely and Effectively
Using grass pollen allergy medication safely requires attention to timing, technique, and awareness of potential interactions or side effects. A proactive approach — beginning treatment before symptoms develop — is consistently more effective than reactive use once the pollen season is underway.
Key safety and usage tips include:
-
Start intranasal corticosteroids early: Begin using nasal sprays at least two weeks before your typical symptom onset to allow the anti-inflammatory effect to build up gradually.
-
Use nasal sprays correctly: Tilt the head slightly forward, insert the nozzle gently, and direct the spray towards the outer wall of the nostril — not the nasal septum. Sniff gently after spraying. Incorrect technique is a common reason for poor response (NHS: How to use nasal sprays).
-
Avoid prolonged use of decongestant nasal sprays: Limit use to no more than seven consecutive days to prevent rebound congestion (rhinitis medicamentosa). Oral decongestants should be avoided in patients with uncontrolled hypertension, heart disease, or those taking MAOIs.
-
Be aware of key drug interactions: Fexofenadine should be taken with water — not fruit juices (including grapefruit, orange, or apple juice) — as these can significantly reduce its absorption. Fexofenadine levels may be raised by erythromycin or ketoconazole. Sedating antihistamines interact with alcohol and other CNS depressants. Always inform your pharmacist or GP of all medicines you are taking.
-
Exercise caution with sedating antihistamines: Avoid driving, alcohol, and operating heavy machinery if using first-generation antihistamines such as chlorphenamine. Even second-generation antihistamines can cause drowsiness in some individuals.
-
Report suspected side effects: If you think you are experiencing a side effect from any allergy medication, you can report it via the MHRA Yellow Card Scheme (available at yellowcard.mhra.gov.uk or through the Yellow Card app).
Patients should seek advice from their GP or pharmacist if symptoms are not adequately controlled after two to four weeks of appropriate treatment, if they develop side effects, or if they experience worsening asthma during the pollen season. If you experience signs of a severe allergic reaction — such as facial swelling, difficulty breathing, or a widespread rash — call 999 or go to your nearest A&E immediately.
Practical non-pharmacological measures — such as monitoring pollen forecasts, wearing wraparound sunglasses outdoors, showering and changing clothes after being outside, and keeping windows closed during high-pollen periods — can meaningfully complement medication and reduce overall allergen exposure. A combined approach, tailored to individual symptom patterns, offers the best outcomes for managing grass pollen allergy effectively and safely.
Frequently Asked Questions
What is the best grass pollen allergy medication available over the counter in the UK?
For most people, a non-sedating antihistamine such as cetirizine or loratadine combined with an intranasal corticosteroid spray such as beclometasone or fluticasone propionate offers the best over-the-counter relief for grass pollen allergy. Both types of medication are widely available at UK pharmacies without a prescription for adults aged 18 and over. A pharmacist can help you choose the most appropriate option based on your predominant symptoms.
Can I take antihistamines every day throughout the grass pollen season?
Yes, second-generation antihistamines such as cetirizine, loratadine, and fexofenadine are safe for daily use throughout the grass pollen season for most adults and children. Taking them regularly, rather than only when symptoms flare, generally provides better symptom control. If you have any underlying health conditions or take other medicines, check with your pharmacist or GP before starting daily use.
How is grass pollen allergy medication different from treatments for year-round allergies?
Grass pollen allergy medication is used seasonally — typically from May to August in the UK — whereas treatments for perennial allergies such as dust mite or pet dander allergy are used year-round. The medications themselves (antihistamines, nasal corticosteroids) are often the same, but the timing and duration of use differ significantly. Allergen immunotherapy for grass pollen is also season-specific and must be started several months before the pollen season.
Can children use grass pollen allergy medication, and are the options different from adults?
Yes, several grass pollen allergy medications are licensed for children, though age restrictions vary by product — for example, fexofenadine 120 mg is licensed from age 12, while loratadine syrup is available for younger children. Sublingual immunotherapy tablets Grazax and Oralair are both licensed for children aged 5 and over. Always check the product's age indication and consult a pharmacist or GP to confirm the appropriate medication and dose for a child.
How do I get a referral for grass pollen immunotherapy on the NHS?
To access grass pollen immunotherapy on the NHS, you need a GP referral to a specialist NHS allergy or clinical immunology service, as all immunotherapy is specialist-initiated. Referral is typically considered when symptoms remain poorly controlled despite optimal first-line pharmacotherapy. Your GP may also arrange allergy testing — such as skin prick testing or specific IgE blood tests — to confirm the diagnosis before referral.
What should I do if my hay fever medication is not working during the pollen season?
If your grass pollen allergy medication is not providing adequate relief after two to four weeks of correct use, speak to your GP or pharmacist, as a combination approach or a change in treatment may be needed. Ensure your nasal spray technique is correct — directing the spray towards the outer nostril wall rather than the septum — as poor technique is a common reason for an inadequate response. If you also have asthma and notice worsening symptoms such as increased reliever inhaler use or a drop in peak flow, seek an urgent medical review.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Heading 6
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
- Item 1
- Item 2
- Item 3
Unordered list
- Item A
- Item B
- Item C
Bold text
Emphasis
Superscript
Subscript
